- Daiichi Sankyo, Inc. (Basking Ridge, NJ)
- …and refinement of analysis data standards for AML as well as solid tumor studies- Leadership of Strategic Initiative and Cross-Functional Collaboration: ... 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is primarily focused on providing novel therapies in … more
- Daiichi Sankyo, Inc. (Basking Ridge, NJ)
- …and refinement of analysis data standards for AML as well as solid tumor studies.- Leadership of Strategic Initiative and Cross-Functional Collaboration: ... 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is primarily focused on providing novel therapies in … more
- Bristol Myers Squibb (Princeton, NJ)
- …medicine and R&D. We have an exciting new opportunity for a Solid Tumor Oncology Diagnostic Sciences Director to join the Translational and Diagnostic ... support of the BMS portfolio. **Summary** The Director of Solid Tumor Oncology Diagnostic Sciences is responsible for providing enterprise capabilities… more
- Bristol Myers Squibb (Princeton, NJ)
- …& Value Demonstration (MAx) access marketing strategy and execution for oncology solid tumors **Responsibilities** + Lead responsibilities for brands/indications ... which may include thoracic products/indications such as Krazati, as well as other solid tumor indications for the IO portfolio + Development of promotional… more
- Bristol Myers Squibb (Princeton, NJ)
- …development of integrated internal and external communications plans and content for BMS' solid tumor oncology portfolio. **Responsibil** **i** **ties:** + ... personal lives. Read more: careers.bms.com/working-with-us . **Position Summary:** Reports to the Director , US Oncology Communications, and serves as an integral… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- …development and refinement of analysis data standards for AML as well as solid tumor studies. - Leadership of Strategic Initiative and Cross-Functional ... 2025 Vision to become a "Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is primarily focused on providing novel therapies in … more
- Memorial Sloan-Kettering Cancer Center (New York, NY)
- …MSK's clinical departments, the Department of Medicine (DoM) encompasses experts in solid tumor oncology , hematologic malignancies, subspecialty medicine and ... supportive and acute care services. Offering a range of services both in multiple sites in New York City and at their suburban outpatient locations in our Regional Care Network (RCN), DoM physicians oversee the care of the whole patient. The RCN serves the… more
